Blue Eye Soft

About Blue Eye Soft: Blue Eye Soft, the groundbreaking multinational corporation of South Carolina Research Authority SC Launch, U.S. Air Force Research Labs CSA cohort, and Innosphere Ventures client company, has paired its AI and computer-aided detection expertise with its fast-moving and innovative market approach to solve problems for commercial and government defense departments worldwide. https://blueyesoft.com/ South Carolina, July 20, 2020 (GLOBE NEWSWIRE) -- Blue Eye Soft, an innovative IT-solutions and software development company, announced that it has received acknowledgment from the U.S. Food and Drug Administration (FDA) of its Pre-Submission package for its proprietary artificial intelligence (AI)-driven medical imaging software, BLUEDOCAITM, to assist with the medical diagnosis of diseases such as COVID-19. BLUEDOCAITM is a clinical decision support tool that uses AI-driven deep learning algorithms to assist radiologists and other healthcare professionals with fast and accurate diagnosis of diseases, such as COVID-19.